VANGUARD HEALTH CARE INDEX FUND is a ETF series of VANGUARD WORLD FUND (series S000004450). Net assets $19.0B as of 2026-05-31. Index fund.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co | — | $2.7B | 1404.46% |
| Johnson & Johnson | — | $1.6B | 846.75% |
| AbbVie Inc | — | $1.2B | 608.61% |
| UnitedHealth Group Inc | — | $1.0B | 544.90% |
| Merck & Co Inc | — | $885.0M | 466.07% |
| Thermo Fisher Scientific Inc | — | $555.7M | 292.67% |
| Amgen Inc | — | $544.7M | 286.84% |
| Gilead Sciences Inc | — | $500.9M | 263.80% |
| Intuitive Surgical Inc | — | $452.1M | 238.09% |
| Pfizer Inc | — | $447.0M | 235.43% |
| Abbott Laboratories | — | $447.0M | 235.41% |
| Bristol-Myers Squibb Co | — | $349.6M | 184.12% |
| Danaher Corp | — | $348.7M | 183.66% |
| CVS Health Corp | — | $346.9M | 182.69% |
| Vertex Pharmaceuticals Inc | — | $341.1M | 179.61% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $19.0B |
| 2026-02-28 | $20.3B |
| 2025-11-30 | $20.4B |
| 2025-08-31 | $17.6B |
| 2025-05-31 | $17.4B |
| 2025-02-28 | $19.8B |
| 2024-11-30 | $20.6B |
| 2024-08-31 | $22.1B |